15.05.2015 Views

Insider manual for Morpol ASA (Primary Insiders)

Insider manual for Morpol ASA (Primary Insiders)

Insider manual for Morpol ASA (Primary Insiders)

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

INSIDER MANUAL FOR<br />

MORPOL <strong>ASA</strong><br />

This <strong>manual</strong> applies <strong>for</strong> employees in leading positions, board members, representatives etc. in<br />

<strong>Morpol</strong> <strong>ASA</strong> (“<strong>Morpol</strong>”)<br />

1. Introduction<br />

1.1 The Norwegian Securities Trading Act (the ”Securities Trading Act”) sets out a general<br />

prohibition against misuse of inside in<strong>for</strong>mation related to financial instruments listed at Oslo<br />

Børs, as well as rules regarding the duty of confidentiality and due care in in<strong>for</strong>mation handling<br />

and prohibition against giving advice, applicable <strong>for</strong> all persons in possession of inside<br />

in<strong>for</strong>mation. Furthermore, the Securities Trading Act sets out special provisions applicable <strong>for</strong><br />

<strong>Primary</strong> <strong>Insider</strong>s (as defined below), including an investigation requirement and a notification<br />

requirement in relation to certain transactions, and a duty to transmit lists of close associates<br />

who hold certain financial instruments to Oslo Børs. <strong>Morpol</strong> has a duty pursuant to the<br />

Securities Trading Act to draw up lists of persons who are given access to inside in<strong>for</strong>mation<br />

which shall be submitted to the Oslo Stock Exchange and the Norwegian Financial Supervisory<br />

Authority at their request, a duty of notification in relation to certain transactions and a duty to<br />

transmit in<strong>for</strong>mation about <strong>Primary</strong> <strong>Insider</strong>s to Oslo Børs.<br />

1.2 It is of great importance to <strong>Morpol</strong> that the authorities’ requirements <strong>for</strong> securities trading are<br />

observed, and the company has there<strong>for</strong>e adopted this primary insider <strong>manual</strong>.<br />

1.3 <strong>Morpol</strong> emphasises that each person is responsible <strong>for</strong> ensuring that his/her securities trading,<br />

including trading executed on his/her behalf, is carried out in accordance with the at all times<br />

prevailing laws and regulations <strong>for</strong> the relevant type of trade.<br />

2. Definitions<br />

”Financial Instruments”<br />

Financial instruments which are issued by <strong>Morpol</strong> and listed<br />

or applied <strong>for</strong> listing on a regulated market, as well as<br />

financial instruments (including options and<br />

futures/<strong>for</strong>wards) whose value depend on such financial<br />

instruments.<br />

The phrase “financial instruments” is defined in Section 2-2<br />

of the Securities Trading Act and includes inter alia shares,<br />

warrants, convertible bonds, bonds, options and<br />

futures/<strong>for</strong>wards.<br />

”Inside In<strong>for</strong>mation”<br />

Precise in<strong>for</strong>mation about Financial Instruments, <strong>Morpol</strong> or<br />

other matters which are suited to influence the price of<br />

Financial Instruments noticeably, and which are not publicly<br />

available or commonly known in the market.<br />

Precise in<strong>for</strong>mation means in<strong>for</strong>mation which indicates that<br />

one or more circumstances or events have occurred or may<br />

reasonably be expected to occur, and which are adequately<br />

specific to draw a conclusion regarding the possible<br />

1/14


influence of these circumstances or events on the price of<br />

Financial Instruments.<br />

In<strong>for</strong>mation that is suited to influence the price of Financial<br />

Instruments noticeably means in<strong>for</strong>mation which a<br />

reasonable investor is likely to use as a part of his/her<br />

investment decision.<br />

“Inside In<strong>for</strong>mation” is defined in Section 3-2 of the<br />

Securities Trading Act<br />

“Transaction”<br />

”<strong>Primary</strong> <strong>Insider</strong>”<br />

”Close Associates”<br />

Subscription, purchase, sale or exchange.<br />

Board member, senior employee, member of audit<br />

committee or auditor associated with <strong>Morpol</strong>; deputy board<br />

member, observer, board secretary or company secretary of<br />

<strong>Morpol</strong>; or board member or senior employee of an entity in<br />

the same group as <strong>Morpol</strong> who can normally be expected to<br />

have access to Inside In<strong>for</strong>mation.<br />

The following natural or legal persons:<br />

1. The spouse of the relevant party or a person with whom<br />

the relevant party cohabits in a relationship akin to<br />

marriage.<br />

2. The under-aged children of the relevant party or underaged<br />

children of a person as mentioned in nr. 1.<br />

3. An undertaking in which<br />

a. the relevant party,<br />

b. a person as mentioned in nr. 1 or 2, or<br />

c. a person with whom the relevant party must be<br />

assumed to be acting in concert in the exercise of<br />

rights accruing to the owner of a Financial<br />

Instrument,<br />

owing to agreement or as owner of shares or company<br />

participations has a determining influence. Determining<br />

influence shall be deemed to exist when the person<br />

owns so many shares or participations that they<br />

represent a majority of the votes of the company, or the<br />

person has the right to elect or remove a majority of the<br />

members of the board of directors of the company.<br />

3. Prohibition against misuse of Inside In<strong>for</strong>mation<br />

3.1 Transactions with Financial Instruments, or incitement of such, shall not be made by <strong>Primary</strong><br />

<strong>Insider</strong>s who are in possession of Inside In<strong>for</strong>mation.<br />

3.2 The prohibition in section 3.1 only applies to misuse of Inside In<strong>for</strong>mation and does not prevent<br />

inter alia the normal per<strong>for</strong>mance of any previously entered into option or future/<strong>for</strong>ward<br />

contract upon expiry of the contract.<br />

3.3 The prohibition in section 3.1 applies <strong>for</strong> Transactions both <strong>for</strong> own and another person’s<br />

account, regardless of whether the Transaction is made in own or another person’s name.<br />

Consequently, it is not possible to evade the prohibition by inventing creative schemes<br />

involving third parties.<br />

2/14


3.4 As a precautionary measure, <strong>Primary</strong> <strong>Insider</strong>s shall desist from Transactions with Financial<br />

Instruments, or incitement of such Transactions, if they are unsure whether they are in<br />

possession of Inside In<strong>for</strong>mation. <strong>Primary</strong> <strong>Insider</strong>s shall in any case properly investigate<br />

whether Inside In<strong>for</strong>mation exists be<strong>for</strong>e such Transactions are carried out (ref. section 6).<br />

3.5 If an assignment <strong>for</strong> a Transaction with Financial Instruments is given but not carried out when<br />

the Inside In<strong>for</strong>mation is made known to the principal, the assignment shall be withdrawn.<br />

Failure to do so may be regarded as a breach of the prohibition in section 3.1.<br />

3.6 The Board of Directors, the Chairman of the Board or the Chief Executive Officer may decide,<br />

without further notice, to adopt a general prohibition against Transactions with Financial<br />

Instruments <strong>for</strong> <strong>Primary</strong> <strong>Insider</strong>s.<br />

4. Duty of confidentiality and due care in in<strong>for</strong>mation handling<br />

4.1 <strong>Primary</strong> <strong>Insider</strong>s who are in possession of Inside In<strong>for</strong>mation shall not pass on such Inside<br />

In<strong>for</strong>mation to unauthorised parties.<br />

4.2 <strong>Primary</strong> <strong>Insider</strong>s who are in possession of Inside In<strong>for</strong>mation shall show due care when<br />

handling such Inside In<strong>for</strong>mation, so that Inside In<strong>for</strong>mation does not come into the possession<br />

of unauthorised parties or is misused.<br />

4.3 <strong>Primary</strong> <strong>Insider</strong>s shall not, under any circumstance, disclose Inside In<strong>for</strong>mation to share<br />

analysts, representatives from the financial market, journalists or representatives of any press<br />

agency without the prior consent of the Chief Executive Officer.<br />

4.4 The duty of confidentiality pursuant to section 4.1 does not prohibit disclosure of Inside<br />

In<strong>for</strong>mation to other employees of <strong>Morpol</strong> as part of ordinary case handling or to advisors of<br />

<strong>Morpol</strong>, if deemed necessary <strong>for</strong> the accomplishment of the employee’s or the advisor’s tasks.<br />

The duty of confidentiality does not prohibit disclosure of Inside In<strong>for</strong>mation to Oslo Børs or<br />

other relevant authorities. All disclosure of Inside In<strong>for</strong>mation shall be made under due<br />

consideration of confidentiality and in accordance with the rules and procedures <strong>for</strong> such<br />

disclosure applicable <strong>for</strong> <strong>Morpol</strong>, including required prior consents from the Chief Executive<br />

Officer or other relevant person or corporate body of the company.<br />

4.5 <strong>Primary</strong> <strong>Insider</strong>s who are employees shall disclose all Inside In<strong>for</strong>mation that get to their<br />

knowledge by virtue of their employment to the Chief Executive Officer or his appointee. The<br />

Inside In<strong>for</strong>mation shall be handed over immediately after coming to the <strong>Primary</strong> <strong>Insider</strong>s’<br />

knowledge.<br />

4.6 If a <strong>Primary</strong> <strong>Insider</strong> as part of <strong>Morpol</strong>’s business is of the opinion that he/her must, or is<br />

contemplating to, grant third parties access to Inside In<strong>for</strong>mation, this shall be approved in<br />

advance by the Chief Executive Officer.<br />

5. Prohibition against giving advice<br />

5.1 <strong>Primary</strong> <strong>Insider</strong>s in possession of Inside In<strong>for</strong>mation shall not give advice on trading in the<br />

Financial Instruments to which the Inside In<strong>for</strong>mation pertains.<br />

5.2 The prohibition in section 5.1 includes advice on desisting from trading.<br />

6. Investigation requirement and clearance requirement<br />

3/14


6.1 <strong>Primary</strong> <strong>Insider</strong>s shall, prior to carrying out or inciting others to carry out Transactions related<br />

to Financial Instruments, properly investigate whether Inside In<strong>for</strong>mation pertains to the<br />

Financial Instruments or <strong>Morpol</strong> exists. The investigation requirement also applies in relation to<br />

entry into, purchase, sale or exchange of option or futures/<strong>for</strong>ward contracts or equivalent rights<br />

related to Financial Instruments, and incitement of such transactions.<br />

6.2 The investigation requirement comprises that each <strong>Primary</strong> <strong>Insider</strong> actively and properly must<br />

investigate whether Inside In<strong>for</strong>mation exists. The <strong>Primary</strong> <strong>Insider</strong> must evaluate which types of<br />

investigations are necessary to carry out in order to comply with the requirement of proper<br />

investigation, and shall always:<br />

- read mail addressed to the <strong>Primary</strong> <strong>Insider</strong> and investigate whether unopened/unclaimed<br />

mail exists, including email;<br />

- within reasonable time become acquainted with matters the <strong>Primary</strong> <strong>Insider</strong> shall participate<br />

in the handling of; and<br />

- ask persons involved in the relevant matters whether they are familiar with the existence of<br />

Inside In<strong>for</strong>mation.<br />

6.3 If the <strong>Primary</strong> <strong>Insider</strong>, after carrying out a proper investigation, concludes that Inside<br />

In<strong>for</strong>mation does not exist, the <strong>Primary</strong> <strong>Insider</strong> shall request a clearance from the Chief<br />

Executive Officer regarding the relevant transaction. Board members and the Chief Executive<br />

Officer shall obtain clearance from the Chairman of the Board. A draft clearance <strong>for</strong>m is<br />

enclosed as annex 1.<br />

6.4 If the Chief Executive Officer/Chairman of the Board concludes that Inside In<strong>for</strong>mation exists,<br />

the request <strong>for</strong> clearance shall be refused. In the opposite case, it shall be approved. Acceptance<br />

or refusal of a request <strong>for</strong> clearance shall be submitted in writing. The transaction is only<br />

regarded as cleared when a binding agreement regarding the transaction is entered into within<br />

seven calendar days after the date of the clearance. If a binding agreement has not been entered<br />

into within this period, a new clearance must be obtained. Requests <strong>for</strong> clearance and responses<br />

shall be in the safekeeping of the <strong>Primary</strong> <strong>Insider</strong> <strong>for</strong> ten years.<br />

6.5 Even if a clearing is granted, the Transaction must not be carried out if the <strong>Primary</strong> <strong>Insider</strong> is in<br />

possession of Inside In<strong>for</strong>mation.<br />

6.6 The clearance requirement in section 6.3 does not prevent the normal per<strong>for</strong>mance of any<br />

previously entered into option or futures/<strong>for</strong>ward contract upon the expiry of such contracts.<br />

7. Notification requirement<br />

7.1 A <strong>Primary</strong> <strong>Insider</strong> shall immediately, and at the latest within the start of trading on Oslo Børs on<br />

the following day, notify Oslo Børs of any Transaction related to shares issued by <strong>Morpol</strong> or a<br />

company in the same group as <strong>Morpol</strong>. The notification requirement also applies with regard to<br />

loans as mentioned in the Norwegian Limited Companies Act Section 11-1 and the Norwegian<br />

Public Limited Companies Act Section 11-1 (including convertible bonds) as well as entry into,<br />

exchange, purchase or sale of warrants, options and corresponding rights connected with shares<br />

issued by <strong>Morpol</strong> or a company in the same group as <strong>Morpol</strong>.<br />

7.2 <strong>Morpol</strong> shall immediately and at the latest within the start of trading on the Oslo Børs on the<br />

following day, notify Oslo Børs of any trade by <strong>Morpol</strong> related to shares issued by <strong>Morpol</strong> or a<br />

company in the same group as <strong>Morpol</strong>. The notification requirement also applies with regard to<br />

loans as mentioned in the Norwegian Limited Companies Act Section 11-1 and the Norwegian<br />

Public Limited Companies Act Section 11-1 as well as entry into, exchange, purchase or sale of<br />

warrants, options and corresponding rights connected with shares issued by <strong>Morpol</strong> or a<br />

company in the same group as <strong>Morpol</strong>.<br />

4/14


7.3 The notification requirement pursuant to section 7.1 also applies to undertakings owning shares<br />

in <strong>Morpol</strong> and which are represented at the board of directors of <strong>Morpol</strong> due to such ownership.<br />

The relevant Board member shall seek to contribute to the undertaking complying with this<br />

notification requirement.<br />

7.4 The notification requirements pursuant to sections 7.1, 7.2 and 7.3 also apply when a<br />

Transaction is executed by Close Associates of the relevant person, regardless of whether the<br />

relevant person has decided on the execution of the Transaction or has participated in the<br />

Transaction.<br />

7.5 A draft <strong>for</strong>m regarding notification as mentioned in sections 7.1 to 7.4 is enclosed as annex 2.<br />

The notification shall contain the following in<strong>for</strong>mation:<br />

- Name of the person subject to notification requirement;<br />

- Background <strong>for</strong> the notification;<br />

- Name of issuer;<br />

- Description of the financial instrument;<br />

- Type of transaction;<br />

- Time and market <strong>for</strong> the Transaction;<br />

- Price and volume of the Transaction; and<br />

- The holding after the Transaction.<br />

With regard to options and other rights, it is necessary to disclose other in<strong>for</strong>mation about the<br />

”price”, including inter alia in<strong>for</strong>mation about the duration of the option, the premium and strike<br />

price.<br />

7.6 At the same time as notifications as mentioned in sections 7.1 to 7.4 is sent to Oslo Børs, a copy<br />

of the notification shall be sent to the Chief Executive Officer of <strong>Morpol</strong>.<br />

7.7 <strong>Morpol</strong> shall without undue delay transmit an updated list of <strong>Primary</strong> <strong>Insider</strong>s and undertakings<br />

as mentioned in section 7.3 to the web-based insider register of Oslo Børs. The Chief Executive<br />

Officer of <strong>Morpol</strong> is responsible <strong>for</strong> drawing up and continuously updating the list. The<br />

notification shall contain the name, the personal identity number or similar identification<br />

number, address, type of office or post in the company, and other employment positions, if any.<br />

7.8 The first time a person is referred to as <strong>Primary</strong> <strong>Insider</strong>, this person shall without undue delay<br />

fill in and transmit an initial notification to <strong>Morpol</strong> with attention to the Chief Executive<br />

Officer. The <strong>Primary</strong> <strong>Insider</strong> shall unsolicited and without undue delay notify the Chief<br />

Executive Officer of any changes made to the initial notification. A draft <strong>for</strong>m regarding such<br />

notification is enclosed as annex 3.<br />

7.9 Persons subject to notification requirements pursuant to sections 7.1, 7.2 and 7.3 shall without<br />

undue delay transmit updated lists of Close Associates holding Financial Instruments or<br />

financial instruments issued by a company in the same group as <strong>Morpol</strong>, or financial<br />

instruments which value is dependent on such financial instruments, to Oslo Børs. The<br />

notification shall contain the personal identity number, company registration number or a<br />

similar identification number.<br />

8. Lists of receivers of Inside In<strong>for</strong>mation<br />

8.1 <strong>Morpol</strong> shall at all times keep lists of persons who are given access to Inside In<strong>for</strong>mation. If a<br />

person who is given access to Inside In<strong>for</strong>mation is a legal person, the list shall include its<br />

employees, representatives, assistants etc. to which the Inside In<strong>for</strong>mation is disclosed.<br />

5/14


8.2 <strong>Morpol</strong> shall make sure that lists as mentioned in section 8.1 are incorporated into a specific<br />

protocol and kept <strong>for</strong> at least five years after preparation or updating, and sent to Oslo Børs and<br />

the Norwegian Financial Supervisory Authority (Finanstilsynet) upon request. Draft lists of<br />

receivers of Inside In<strong>for</strong>mation are enclosed as annex 4 (in Norwegian and English versions). A<br />

draft statement regarding confidentiality and trade prohibition <strong>for</strong> ”unauthorised persons” is<br />

enclosed as annex 5.<br />

8.3 <strong>Morpol</strong> shall ensure that persons who are given access to Inside In<strong>for</strong>mation is familiar with the<br />

applicable duties and responsibilities, as well as the criminal liability related to misuse or<br />

unauthorised distribution of Inside In<strong>for</strong>mation. <strong>Morpol</strong> shall upon request present<br />

documentation to Oslo Børs the Norwegian Financial Supervisory Authority (Finanstilsynet),<br />

evidencing that the persons granted access to Inside In<strong>for</strong>mation has been made aware of the<br />

abovementioned duties and responsibilities.<br />

9. Penalties and sanctions<br />

9.1 Wilful or negligent violation of the provisions in the Securities Trading Act on misuse of Inside<br />

In<strong>for</strong>mation, duty of confidentiality and due care in in<strong>for</strong>mation handling or prohibition against<br />

giving advice, investigation requirement, notification requirement or duty to draw up lists of<br />

receivers of Inside In<strong>for</strong>mation, or complicity thereto, is a criminal offence pursuant to the<br />

Securities Trading Act Section 17-3.<br />

9.2 Any person who wilfully or negligently misuses Inside In<strong>for</strong>mation, or contributes thereto, is<br />

liable to punishment by fines or imprisonment up to six years.<br />

9.3 Any person who wilfully or negligently violates the duty of confidentiality and due care of<br />

in<strong>for</strong>mation handling, the prohibition against giving advice, the investigation requirement, the<br />

notification requirement or the duty to draw up lists of receivers of Inside In<strong>for</strong>mation, or<br />

contributes thereto, is punished by fines or imprisonment up to one year.<br />

9.4 This <strong>manual</strong> is part of the company regulations of <strong>Morpol</strong>. Any breach of this <strong>manual</strong> may<br />

affect the offender’s employment.<br />

6/14


* * *<br />

DECLARATION BY PRIMARY INSIDERS OF MORPOL <strong>ASA</strong><br />

I have reviewed, read and understood the content of the primary insider <strong>manual</strong> <strong>for</strong> <strong>Morpol</strong> <strong>ASA</strong>, and<br />

will comply with it in its entirety.<br />

Place/date:<br />

________________, ____________<br />

Name:<br />

___________________________________<br />

Title/position: ___________________________________<br />

Signature:<br />

___________________________________<br />

7/14


ANNEX 1<br />

REQUEST FOR CLEARING OF TRANSACTION WITH<br />

FINANCIAL INSTRUMENTS ISSUED BY MORPOL <strong>ASA</strong> OR RELATED FINANCIAL<br />

INSTRUMENTS<br />

To the Chief Executive Officer of <strong>Morpol</strong> <strong>ASA</strong><br />

The undersigned requests clearance <strong>for</strong> _____________________ (transaction type, e.g. purchase, sale or exchange)<br />

of ______________ (number)<br />

________________________________________________________ (description of financial instruments).<br />

The undersigned is, after having carried out proper investigations, not aware of in<strong>for</strong>mation about the<br />

financial instruments, <strong>Morpol</strong> <strong>ASA</strong> or other circumstances, which may affect the price of the financial<br />

instruments or related financial instruments noticeably, and which is not publicly available or<br />

commonly known in the market. All mail and email addressed to the undersigned until and including<br />

today has been read, and it has been checked that no mail remains unclaimed. To the extent the<br />

undersigned is aware of ongoing processes within the company or the group which may cause<br />

in<strong>for</strong>mation as mentioned, the undersigned has discussed this with the relevant persons.<br />

Place/date:<br />

Name:<br />

________________, ____________<br />

___________________________________<br />

Signature:<br />

___________________________________<br />

----------------------------------------------------------------------------------------------------------------------<br />

DECLARATION BY THE CHIEF EXECUTIVE OFFICER<br />

In the opinion of the undersigned, there<br />

<br />

<br />

does not exist<br />

does exist<br />

in<strong>for</strong>mation about the financial instruments, <strong>Morpol</strong> <strong>ASA</strong> or other circumstances, which may affect<br />

the price of the financial instruments or related financial instruments noticeably, and which is not<br />

publicly available or commonly known in the market.<br />

If the transaction is approved: If the transaction is not carried out within seven calendar days after<br />

signing of this declaration, a new declaration must be submitted. Please note that the transaction<br />

cannot be carried out if in<strong>for</strong>mation of the abovementioned nature is received.<br />

Place/date:<br />

________________, ____________<br />

Signature:<br />

___________________________________<br />

8/14


ANNEX 2<br />

NOTICE TO OSLO BØRS ON TRADE SUBJECT TO NOTIFICATION REQUIREMENT<br />

UNDER THE SECURITIES TRADING ACT SECTION 4-1<br />

When trade is subject to notification requirement under the Securities Trading Act Section 4-1, the<br />

person subject to the notification requirement shall immediately, and no later than at the start of<br />

trading on Oslo Børs on the day following the trade, send this <strong>for</strong>m to Oslo Børs by email to<br />

ma@oslobors.no or telefax +47 22 41 65 90, with a copy to the chief executive officer of <strong>Morpol</strong><br />

<strong>ASA</strong>.<br />

Name of person subject to notification requirement: ____________________________________________<br />

Who the transaction has been carried out by:<br />

(a)<br />

(b)<br />

of the person subject to notification requirement<br />

(c)<br />

of a person as mentioned in (a) or (b)<br />

The person subject to notification requirement<br />

<br />

The spouse/cohabitant/under-age children<br />

<br />

An undertaking under the control/influence<br />

<br />

Background <strong>for</strong> the notification:<br />

___________________________________________________<br />

Description of the financial instrument:<br />

___________________________________________________<br />

Name of the issuer:<br />

___________________________________________________<br />

Type of transaction (purchase, sale etc.):<br />

___________________________________________________<br />

Timing and market <strong>for</strong> the transaction:<br />

___________________________________________________<br />

Price and volume of the transaction:<br />

___________________________________________________<br />

Holding after the transaction:<br />

___________________________________________________<br />

Place/date:<br />

________________, ____________<br />

Signature:<br />

___________________________________<br />

9/14


ANNEX 3<br />

FIRST-TIME NOTIFICATION TO MORPOL <strong>ASA</strong><br />

To the Chief Executive Officer of <strong>Morpol</strong> <strong>ASA</strong><br />

1. The person subject to notification requirement<br />

Name:<br />

Address:<br />

_____________________________________________________________<br />

_____________________________________________________________<br />

Personal identification no.: ____________________________________________________<br />

VPS account no.: ____________________________________________________________<br />

Type of position: ____________________________________________________________<br />

Telephone (work): _____________________ Telephone (private): _____________________<br />

2. Spouse or cohabitant, as well as own or cohabitant’s underaged children living in the<br />

same household, who own shares of <strong>Morpol</strong> <strong>ASA</strong> or companies in the same group<br />

Spouse/cohabitant<br />

Name:<br />

_____________________________________________________________<br />

Personal identification no.: ____________________________________________________<br />

VPS account no.:____________________________________________________________<br />

Under-age children<br />

Name:<br />

_____________________________________________________________<br />

Personal identification no.: ____________________________________________________<br />

VPS account no.:____________________________________________________________<br />

Name:<br />

_____________________________________________________________<br />

Personal identification no.: ____________________________________________________<br />

VPS account no.:____________________________________________________________<br />

10/14


3. Determining influence in another company<br />

Do any persons as mentioned under item 1 or 2 have ownership interests or in any other way<br />

determining influence in another company?<br />

Yes<br />

No<br />

<br />

<br />

If yes, state company name and registration number:<br />

____________________________________________________________________<br />

____________________________________________________________________<br />

____________________________________________________________________<br />

____________________________________________________________________<br />

4. Holding of financial instruments issued by <strong>Morpol</strong> <strong>ASA</strong><br />

Holding of financial instruments (state type) issued by <strong>Morpol</strong> and owned by:<br />

The person subject to notification requirement: ____________________________________<br />

Spouse/cohabitant/children:<br />

Company as mentioned under item 3:<br />

____________________________________<br />

____________________________________<br />

***<br />

Amendments to disclosed in<strong>for</strong>mation shall be reported to <strong>Morpol</strong> <strong>ASA</strong> on a <strong>for</strong>m similar to this.<br />

Place/date:<br />

________________, ____________<br />

Signature:<br />

___________________________________<br />

11/14


Konfidensielt<br />

ANNEX 4a<br />

Liste over mottakere av innsidein<strong>for</strong>masjon (jf. verdipapirhandelloven av 2007 § 3-5)<br />

• Listen skal inneholde detaljer om samtlige fysiske og juridiske personer som har fått tilgang til innsidein<strong>for</strong>masjon.<br />

• Listen skal til enhver tid holdes oppdatert.<br />

• Listen skal oppbevares i minst 5 år, og skal ved <strong>for</strong>espørsel sendes til Finanstilsynet og Oslo Børs.<br />

• Reglene i verdipapirhandelloven kapittel 3 vil komme til anvendelse, herunder bestemmelsene om misbruk av innsidein<strong>for</strong>masjon, taushetsplikt og tilbørlig<br />

in<strong>for</strong>masjonshåndtering, undersøkelsesplikt <strong>for</strong> primærinnsidere og rådgivnings<strong>for</strong>bud. Brudd på disse reglene kan være straffbart.<br />

• Personer som har fått tilgang til innsidein<strong>for</strong>masjon skal bekrefte at de er kjent med de plikter og ansvar dette innebærer, samt straffeansvaret som er<br />

<strong>for</strong>bundet med misbruk eller uberettiget distribusjon av slike opplysninger. Signering av dette dokumentet anses å innebære slik bekreftelse.<br />

Selskap (ticker code)<br />

Opprettet (dato)<br />

Oppdatert (dato)<br />

Prosjekt / sak<br />

[•]<br />

[•]<br />

[•]<br />

[•]<br />

Navn Stilling Kontaktdetaljer<br />

Årsak til mottak/tilgang og<br />

in<strong>for</strong>masjonens innhold<br />

Tidspunkt <strong>for</strong><br />

mottak/tilgang<br />

Dato <strong>for</strong><br />

oppføring/endring Signatur<br />

12/14


Confidential<br />

ANNEX 4b<br />

List of persons with access to inside in<strong>for</strong>mation (ref. the Norwegian Securities Trading Act of 2007 section 3-5)<br />

• The list shall include details of all individuals and legal persons that have been given access to inside in<strong>for</strong>mation.<br />

• The list shall be kept updated at all times.<br />

• The list shall be stored <strong>for</strong> at least 5 years and shall upon request be sent to Finanstilsynet (The Financial Supervisory Authority of Norway) and Oslo Børs.<br />

• The rules in the Norwegian Securities Trading Act chapter 3 will apply, hereunder rules on misuse of inside in<strong>for</strong>mation, confidentiality and due care in<br />

handling of in<strong>for</strong>mation, duty to investigate <strong>for</strong> primary insiders and prohibition against giving advice. Violation of such rules may be a criminal offence.<br />

• The persons that have been given access to inside in<strong>for</strong>mation shall confirm that they are aware of the duties and responsibilities this involves, including the<br />

criminal liability associated with misuse or unwarranted distribution of such in<strong>for</strong>mation. Signing of this document is deemed to constitute such confirmation.<br />

Company (ticker code)<br />

[•]<br />

Created (date)<br />

[•]<br />

Updated (date)<br />

[•]<br />

Project / case<br />

[•]<br />

Name Position Contact details<br />

Reason <strong>for</strong> reception/access and<br />

content of the in<strong>for</strong>mation<br />

Time of<br />

reception/access<br />

Record<br />

date/amended<br />

Signature<br />

13/14


ANNEX 5<br />

CONFIDENTIALITY STATEMENT<br />

The undersigned hereby irrevocably declares to keep confidential all in<strong>for</strong>mation which is not publicly<br />

available or commonly known in the market regarding <strong>Morpol</strong> <strong>ASA</strong> (“<strong>Morpol</strong>”) which will be<br />

disclosed to the undersigned in relation to [insert in<strong>for</strong>mation on the nature of the<br />

in<strong>for</strong>mation/disclosure], and undertakes not to enter into any agreement regarding purchase, sale or<br />

subscription of financial instruments issued by <strong>Morpol</strong> or rights to such financial instruments, until the<br />

in<strong>for</strong>mation has been made publicly available or is commonly known in the market or is not suited to<br />

affect the price of the financial instruments.<br />

* * *<br />

Place/date:<br />

________________, ____________<br />

Name:<br />

___________________________________<br />

Signature:<br />

___________________________________<br />

14/14

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!